Loading...
Loading...
India's amino imports from UNITED STATES total $1.7M across 260 shipments from 15 foreign suppliers. M/S. ENDO USA, INC leads with $1.2M in import value; the top 5 suppliers together control 83.6% of this origin. Leading Indian buyers include PAR FORMULATIONS PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for amino — a diversified sourcing base with multiple active suppliers from UNITED STATES.

M/S. ENDO USA, INC is the leading Amino supplier from UNITED STATES to India, with import value of $1.2M across 7 shipments. The top 5 suppliers — M/S. ENDO USA, INC, ENDO PHARMACEUTICALS SOLUTIONS INC., AMSTERDAM PHARMA(APTEKA RX INC), APTEKA RX INC. (AMSTERDAM PHARMA), AMSTERDAM PHARMA(APTEKA RX INC.) — collectively account for 83.6% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | M/S. ENDO USA, INC | $1.2M | 7 | 69.3% |
| 2 | ENDO PHARMACEUTICALS SOLUTIONS INC. | $73.2K | 27 | 4.4% |
| 3 | AMSTERDAM PHARMA(APTEKA RX INC) | $71.8K | 4 | 4.3% |
| 4 | APTEKA RX INC. (AMSTERDAM PHARMA) | $48.7K | 2 | 2.9% |
| 5 | AMSTERDAM PHARMA(APTEKA RX INC.) | $46.1K | 37 | 2.7% |
| 6 | ESPEE BIOPHARMA & FINECHEM LLC | $38.2K | 7 | 2.3% |
| 7 | NILSCH LLC | $25.9K | 8 | 1.5% |
| 8 | AKRON PHARMA | $24.8K | 12 | 1.5% |
| 9 | AMSTERDAM PHARMA APTEKA RX INC | $23.5K | 20 | 1.4% |
| 10 | AMSTERDAM PHARMA | $18.6K | 4 | 1.1% |
| 11 | AMSTERDAM PHARMA ( APTEKA RX INC. ) | $16.1K | 3 | 1.0% |
| 12 | AMSTERDAM PHARMA (APTEKA RX INC) | $13.2K | 8 | 0.8% |
| 13 | HEALTH CARE II DRUGS,INC | $12.8K | 1 | 0.8% |
| 14 | ENDO PHARMACEUTICALS SOLUTIONS INC | $10.5K | 1 | 0.6% |
| 15 | AMSTERDAM PHARMA (APTEK RX INC) | $10.5K | 2 | 0.6% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | PAR FORMULATIONS PRIVATE LIMITED | $1.3M | 36 | 74.7% |
| 2 | CIPLA LIMITED | $186.2K | 21 | 11.1% |
| 3 | DR.REDDY'S LABORATORIES LTD | $28.9K | 32 | 1.7% |
| 4 | AMNEAL PHARMACEUTICALS PRIVATE LIMITED | $24.9K | 12 | 1.5% |
| 5 | KJD PHARMA PRIVATE LIMITED | $24.8K | 12 | 1.5% |
| 6 | INTAS PHARMACEUTICALS LIMITED | $23.2K | 9 | 1.4% |
| 7 | STERISCIENCE SPECIALTIES PRIVATE LIMITED | $18.6K | 4 | 1.1% |
| 8 | DR.REDDY'S LABORATORIES LIMITED | $17.3K | 8 | 1.0% |
| 9 | DR REDDYS LABORATORIES LIMITED | $14.7K | 15 | 0.9% |
| 10 | ETICO LIFESCIENCES PRIVATE LIMITED | $12.5K | 5 | 0.7% |
| 11 | DR REDDY S LABORATORIES LTD | $10.0K | 6 | 0.6% |
| 12 | PUNISKA HEALTHCARE PRIVATE LIMITED | $9.9K | 1 | 0.6% |
| 13 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $9.0K | 5 | 0.5% |
| 14 | ZYDUS LIFESCIENCES LIMITED | $8.2K | 5 | 0.5% |
| 15 | AUROBINDO PHARMA LTD | $8.1K | 9 | 0.5% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Amino suppliers from UNITED STATES to India include M/S. ENDO USA, INC, ENDO PHARMACEUTICALS SOLUTIONS INC., AMSTERDAM PHARMA(APTEKA RX INC). The leading supplier is M/S. ENDO USA, INC with import value of $1.2M USD across 7 shipments. India imported Amino worth $1.7M USD from UNITED STATES in total across 260 shipments.
India imported Amino worth $1.7M USD from UNITED STATES across 260 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Amino sourced from UNITED STATES include PAR FORMULATIONS PRIVATE LIMITED, CIPLA LIMITED, DR.REDDY'S LABORATORIES LTD. The largest buyer is PAR FORMULATIONS PRIVATE LIMITED with $1.3M in imports across 36 shipments.
The total value of Amino imports from UNITED STATES to India is $1.7M USD, across 260 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
260 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists